Previous Article | Next Article ![]()
Eukaryotic Cell, February 2002, p. 119-125, Vol. 1, No. 1
1535-9778/02/$04.00+0 DOI: 10.1128/EC.01.1.119-125.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710
Received 27 August 2001/ Accepted 22 November 2001
|
|
|---|
|
|
|---|
For S. cerevisiae, all identified CaM binding proteins that are essential for growth under normal circumstances do not require Ca2+ binding, consistent with the importance of the Ca2+-independent roles of CaM in this organism. However, several critical functions for Ca2+-dependent CaM targets, calcineurin and CaM kinases, have been identified for S. cerevisiae, including survival of pheromone-induced growth arrest (3, 4, 29, 45), salt tolerance (1, 12, 15, 28, 31), and acquired thermotolerance (18). In S. pombe, no Ca2+-independent targets of CaM essential for growth have been identified. Whereas calcineurin is not essential for growth (47), other Ca2+/CaM-dependent enzymes, such as the serine/threonine kinase CMK, have been identified but not evaluated in the context of gene deletion studies. Thus, neither S. pombe nor S. cerevisiae provides a system in which Ca2+-regulated CaM structure-function relationships can be studied in vitro and in vivo in the context of known essential Ca2+/CaM-dependent targets.
In contrast to the yeasts, other fungi such as A. nidulans and Cryptococcus neoformans do contain genes encoding Ca2+/CaM binding proteins that are essential for growth. In C. neoformans, the fungal pathogen that causes meningitis in immunocompromised patients, both calcineurin A and B genes are required for growth at 37°C and for virulence (11, 33). The filamentous fungus A. nidulans possesses both Ca2+-dependent and Ca2+-independent targets of CaM that are essential for growth. In A. nidulans, four Ca2+/CaM-dependent enzymes, consisting of three serine/threonine protein kinases and one phosphatase (calcineurin), are homologous to known mammalian enzymes, and three of the four are essential. The protein kinases CMKA/CMPK and CMKB are required for the G2-to-M transition and for the reentry of spores into the proliferative cycle, respectively(7, 20), whereas calcineurin is required in G1 (39, 32). On the other hand, A. nidulans also possesses Ca2+-independent targets of CaM, such as the class I myosin MyoA, that are essential for growth (24).
We have examined structural requirements of A. nidulans CaM both in vitro and in vivo. First, we demonstrate that Ca2+ binding is essential for the activation of CMKA and CMKB and is required to support growth in A. nidulans. Although vertebrate CaM appears to bind most CaM binding proteins in A. nidulans extracts, it is unable to fully activate CMKA and CMKB and only partially supports growth in the absence of endogenous CaM. Analysis of chimeras between A. nidulans and vertebrate CaM demonstrates that the N-terminal domain of VCaM harbors variations resulting in a severe defect in the activation of CMKA. However, neither chimeric CaM fully complements the loss of endogenous CaM in A. nidulans. These results demonstrate that while the CaM amino acid sequence is highly conserved, the protein does possess subtle sequence and structural variations that can dramatically alter the essential functions of the molecule in an organism-specific manner.
|
|
|---|
Generation of CaM expression vectors. A multistep process was used to generate a CaM expression plasmid containing the gpdA promoter, the pyroA nutritional marker, and the trpC terminator sequence. First, a 1.42-kb XbaI/NcoI fragment of pAN 7-1 was ligated into a 4.75-kb XbaI/NcoI fragment of pAN 8-1 (both pAN 7-1 and 8-1 were gifts of A. M. J. J. Van Den Hondel [36]) to generate pAN 8-7. Second, pAN 8-7 was digested with XbaI, blunt ended, and digested with EcoRI. The resulting 3.22-kb fragment, containing the gpdA promoter and trpC terminator, was subcloned into the EcoRI and blunted PstI sites of pSX, pUC18 containing the 2.5-kb pyroA nutritional marker, thus generating pSXG. All CaMs were expressed as hemagglutinin (HA)-tagged fusion proteins to facilitate detection. The HA epitope was incorporated into the A. nidulans CaM cDNA by PCR, and the PCR product was cloned into NcoI/BamHI-digested pSXG as an AflIII/BamHI fragment generating pSXG-AnCaM. The S. cerevisiae (gift of T. Davis) cDNA and all A. nidulans mutant cDNAs were subcloned into the NcoI/BamHI-digested pSXG-AnCaM. The chicken CaM cDNA was subcloned into the NcoI and blunted BamHI sites as an NcoI/blunted XbaI fragment from pCaMpl (37). All point mutations and chimeric CaM cDNAs were generated using the megaprimer PCR-based mutagenesis technique (42). All CaM cDNAs were sequenced prior to use.
Ectopic CaM expression in A. nidulans. A. nidulans strains used in this study are listed in Table 1. The AlcCaM strain of A. nidulans was transformed with the CaM expression vectors by either electroporation (41) or conventional polyethylene glycol-mediated transformation (22). The control strains were generated by transforming the GR5 strain with pAL5 and pSXG vectors and the AlcCaM strain with pSXG. Positive transformants were screened for ectopic CaM protein expression. Extracts were generated from spores germinated for 15 h in MMG. Following filtration, the mycelia were frozen in liquid N2. The frozen mycelia were ground in a cold mortar and pestle in protein extraction buffer (50 mM Tris [pH 7.5], 5 mM EDTA, 10 mM benzamidine, 1 µg of pepstatin A/ml, 1 µg of leupeptin/ml and 1 µg of aprotinin/ml). The protein extracts were clarified by centrifugation at 16,000 x g for 10 min at 4°C. Western analysis was performed using 100 µg of crude protein extract, the 12CA5 anti-HA antibody (Boehringer-Mannheim, Indianapolis, Ind.), goat anti-mouse horseradish peroxidase-conjugated immunoglobulin G (Jackson Laboratory, Bar Harbor, Maine), and the Enhanced Chemiluminescence kit (Amersham, Piscataway, N.J.).
|
View this table: [in a new window] |
TABLE 1. A. nidulans strains used in this study
|
A. nidulans growth. The ability of the ectopically expressed CaMs to functionally complement the absence of wild-type CaM was determined by a colony diameter assay as described by McGoldrick et al. (24). Briefly, the spores were diluted and plated on either MMG or MMD agar plates at a concentration of approximately four spores per plate. The average colony diameter was measured every 24 h for 5 days.
Calmodulin overlay. CaM overlay was performed using protein A-CaM fusion proteins as described by Stirling et al. (43). The protein A-CaM fusion proteins were generated in a multistep process. First, pALP1 (gift of M. Stark) was digested with EcoRI, blunted, and digested with BamHI. A HA-tagged A. nidulans CaM cDNA PCR product was subcloned as a blunted AflIII/BamHI fragment, generating pALP-AnCaM. To place the chicken CaM and the four-Ca2+-binding-site mutant CaM into the pALP1 vector as HA-tagged protein A CaM fusion proteins, the cDNAs were first shuttled into the blunted EcoRI/BamHI sites of the original pALP1 plasmid as PvuII/BamHI fragments from the pSXG-based expression plasmids described above. Finally, the cDNAs were interchanged with the AnCaM cDNA in pALP-AnCaM as NcoI/BamHI fragments, thereby creating pALP-VCaM and pALP-1234. The S. cerevisiae CaM-protein A fusion protein was expressed using pDS100 that was kindly provided by M. Stark (43). The fusion proteins were expressed constitutively in BL-21 bacteria and purified on phenyl-Sepharose resin (38). The concentration of the CaM fusion protein used in the overlay medium was 175 nM (6 µg/ml).
CaM kinase purification and assays.
The CaM concentrations required for half-maximal kinase activation (KCaM) of both CMKA and CMKB were determined using bacterially expressed hexa-histidine-tagged protein kinases and bacterially expressed CaM. Both CMKA and CMKB were subcloned into pTrcHisB (Invitrogen, Carlsbad, Calif.) independently, CMKA as a SacI/EcoRI fragment and CMKB as a BamHI/EcoRI fragment. The kinases were expressed and purified as described by Joseph and Means (20). Kinase assays were performed in 30-µl reaction mixtures in a buffer containing 50 mM Tris (pH 7.5), 10 mM MgCl2, 1 mM CaCl2, 1 mM dithiothreitol, 0.1% Tween 20, 200 µM ATP, 0.2 µl of [
-32P]ATP/reaction, and a 200 µM concentration of the peptide substrate ADR1G (LKKLTRRASFSGQ) (8). CaM was added to reactions at various concentrations up to 1 µM, and the reactions were initiated with the addition of either 200 or 400 ng of CMKB and incubated at 30°C for either 5 or 10 min for CMKA and CMKB, respectively. The reactions were terminated by transferring 20 µl of the reaction mixture onto p81 phosphocellulose filters (Millipore, Bedford, Mass.), followed by extensive washing in 75 mM phosphoric acid (9). The specific activity was determined following liquid scintillation counting of the dried filters.
|
|
|---|
|
View larger version (23K): [in a new window] |
FIG. 1. Alignment of A. nidulans CaM with vertebrate and S. cerevisiae CaMs. The A. nidulans (40) (J05545), vertebrate (M36167), and S. cerevisiae (6) (P06787) CaM sequences were aligned using FASTA and shaded by BOXSHADE. Asterisks indicate the Glu residues mutated to Ala to generate the Ca2+-binding mutant CaM. The junction of the A. nidulans/vertebrate chimeric CaMs lies between the amino acids marked with pluses.
|
![]() View larger version (88K): [in a new window] |
FIG. 2. Identification of A. nidulans CaM binding proteins by overlay assay. A. nidulans crude protein extract was separated by polyacrylamide gel electrophoresis, transferred to an Immobilon-P membrane, and probed with either A. nidulans CaM, vertebrate CaM , S. cerevisiae CaM, or the Ca2+ binding mutant CaM-protein A fusion protein. The blots are identical exposures of 100 µg of crude protein extract probed in the presence of Ca2+ as described in Materials and Methods.
|
![]() View larger version (16K): [in a new window] |
FIG. 3. Activation of CMKA and CMKB by A. nidulans and heterologous CaMs. The specific activity of hexa-histidine-tagged bacterially expressed and purified CMKA (A) and CMKB (B) was measured at different concentrations of purified AnCaM (closed square), VCaM (closed circle), ScCaM (closed triangle), or 1234 (closed diamond) CaM as described in Materials and Methods. The graphs are representative of three independent experiments.
|
|
View this table: [in a new window] |
TABLE 2. CaM expression in medium containing glycerol or glucose
|
|
View this table: [in a new window] |
TABLE 3. Activation of A. nidulans CaM kinases
|
![]() View larger version (18K): [in a new window] |
FIG. 4. Complementation of A. nidulans by heterologous CaMs. AlcCaM strains expressing the ectopically expressed AnCaM (open squares), VCaM (closed circles), ScCaM (open circles), and 1234 (closed triangles) were inoculated onto either MMG (A) or MMD (B) agar plates, and their colony diameters were measured over a period of 5 days. A nutritionally complemented pAL5#1 strain (open triangles) was used to represent wild-type A. nidulans (positive control), and the nutritionally complemented AlcCaM strain (closed squares) was used as a negative control.
|
The N terminus of CaM is critical for proper activation of CMKA and CMKB. Since VCaM cannot fully complement A. nidulans CaM despite sharing 84% amino acid identity, we questioned whether the amino acid differences responsible could be localized to the N- or C-terminal lobe of the protein. The C terminus is more divergent between these species, so we predicted that it would be most important in determining functional differences in vitro and in vivo. We created two chimeric CaM cDNAs in which the N- and C-terminal globular domains of the A. nidulans and vertebrate CaM are interchanged. The junction of the proteins (Fig. 1) is following Asn 61, so the chimeras generated are the Aspergillus N terminus-vertebrate C terminus (ANVC) or the Aspergillus C terminus-vertebrate N terminus (VNAC) proteins. First, we tested the activation of CMKA and CMKB by ANVC and VNAC (Table 3). Notably, the KCaM for CMKA using ANVC is similar to that obtained with AnCaM rather than to that obtained with VCaM. In contrast, the KCaM using VNAC falls between the values obtained with AnCaM and VCaM. Both chimeric CaMs demonstrate intermediate effects on Vmax for CMKA. Interestingly, the chimeras display only subtle differences in ability to activate CMKB and are most similar to AnCaM. These biochemical assays support two conclusions: first, the activation of CMKA is more sensitive to differences in the CaM sequence than that of CMKB, and second, amino acid variations in the N terminus, not the C terminus, of VCaM are the most important in determining the KCaM for activation of CMKA.
Both the N and C termini of AnCaM are required for normal growth. If the activation parameters of CMKA in vitro correlate with the ability to support growth in vivo, then ANVC would be better able to support the growth of the fungus than VNAC in the absence of endogenous CaM. To test this, the cDNAs were expressed in the AlcCaM strain, and their ability to support growth was compared to that of AnCaM and VCaM. When germinated in glycerol, all of the strains grew at approximately the same rate (Fig. 5A). However, when germinated in glucose, which represses expression of the endogenous CaM, the strains containing the chimeric proteins at two to four times the level of endogenous CaM (Table 2) grew to an intermediate diameter two-thirds that of the wild type but significantly greater than that of AlcCaM/VCaM (Fig. 5B). Thus, even though ANVC and VNAC demonstrate differences in biochemical properties in vitro, these two chimeric proteins behave similarly in vivo and neither can completely complement the absence of endogenous CaM.
![]() View larger version (14K): [in a new window] |
FIG. 5. Complementation of A. nidulans by A. nidulans/vertebrate chimeric CaMs. The AlcCaM strains expressing AnCaM (open squares), VCaM (closed circles), VNAC (open circles) and ANVC (closed triangles) were grown on either MMG (A) or MMD (B) agar plates, and growth was quantified by measuring colony diameter over a period of 5 days. The nutritionally complemented pAL5#1 strain (open triangles) was used to represent the wild-type A. nidulans (positive control), and the nutritionally complemented AlcCaM strain (closed squares) was used as a negative control.
|
|
|
|---|
Despite sharing 84% amino acid identity with AnCaM, VCaM is unable to fully substitute for AnCaM in vitro or in vivo. Although the CaM overlays showed that AnCaM and VCaM interact with similar spectra of proteins present in A. nidulans crude extracts, VCaM cannot maximally activate either of A. nidulans' essential Ca2+/CaM-dependent protein kinases, CMKA and CMKB. For both enzymes, the Vmax is reduced relative to AnCaM, but the most striking defect is an eightfold increase in KCaM for CMKA. In correlation with these biochemical results, VCaM only partially complements the loss of AnCaM in vivo. This result is in stark contrast to results of studies with both budding and fission yeast, where VCaM and the endogenous CaM are functionally interchangeable in vivo (5, 30, 34).
Between AnCaM and VCaM, there are only 23 amino acid differences, 13 of which are conservative. Examination of the contacts between vertebrate Ca2+/CaM- and CaM binding peptides based on available three-dimensional X-ray crystal and nuclear magnetic resonance structures reveals that only five of the variant residues interact with CaM binding peptides (10, 19, 25, 26, 35), whereas the other 19 residues lie outside of the CaM/CaM binding peptide interfaces. Although the residues involved in peptide binding may be implicated in the inability of VCaM to complement AnCaM, results of prior biochemical and genetic studies argue that the solvent-exposed residues of CaM are also critical for enzyme activation. Biochemically, both AnCaM/VCaM chimeras are able to rescue the ability of VCaM to activate CMKB. However, the results with CMKA are markedly different. For CMKA the amino acid variation in the N-terminal globular domain is largely responsible for the inability of VCaM to fully activate the kinase. The KCaM for ANVC is similar to that of AnCaM, while the KCaM for VNAC is much greater than that of AnCaM. Within the N-terminal domain of AnCaM and VCaM there are only nine amino acid differences. Intriguingly, amino acids 9 to 12, just prior to the first EF hand, differ in three out of four residues. For AnCaM these residues are VSEY, but for VCaM (as well as for ScCaM and the CaMs of several other lower eukaryotes) these residues are IAEF. Both Ala10 and Phe12 interact with CaM binding peptides in crystallographic studies, and mutation of Phe12 to Ala reduces the ability of ScCaM to activate both S. cerevisiae calcineurin and Cmk1p (16). Based on these results, it seems reasonable to suggest that this four-amino-acid cluster may be functionally important. Another difference of potential significance lies at the fourth residue of the second EF hand, Asn in AnCaM and Gly in most other CaMs. Genetic studies of Paramecium identified a mutation at this position (Gly59 to Ser) that abrogates the function of Ca2+-dependent Na+ channels in vivo (21). Interestingly, the Gly-to-Asn variation is also found in the fourth position of the third EF hand in AnCaM. Although these amino acid differences can be speculated to result in biochemical and/or biological consequences, the actual residue or residues responsible for the functional differences cannot be conclusively identified based solely on sequence or structural analysis, since variation in residues within the hydrophobic pockets, on the outer surface of the CaM molecule, or in internally located residues that contribute to stabilizing the structure of the molecule are all potential culprits.
Amino acid substitutions in both globular domains of CaM contribute to the inability of VCaM to fully support growth. Surprisingly, both ANVC and VNAC support A. nidulans growth to roughly the same degree, better than VCaM but not as well as AnCaM, even though the biochemical deficits of VCaM can be largely attributed to the N-terminal globular domain. Although the activation of CMKA and CMKB correlates with the ability of ScCaM, VCaM, and 1234 to support growth in vivo, the analysis of the AnCaM/VCaM chimeras indicates that the in vivo phenotype cannot be simply attributed to the efficacy of these proteins to activate CaMKs. Indeed, several studies suggest that reductions in CaMK activity may not severely impact the in vivo functions of the enzyme. Previous work in our laboratory has demonstrated that for A. nidulans, a discernible growth phenotype is observed only when CMKA protein expression (and presumably activity) is repressed to undetectable levels (7). Similarly, in S. cerevisiae, biochemical and in vivo analyses of CaM Phe-to-Ala mutants demonstrate that mutations that subtly attenuate calcineurin and CaMK activation in vitro do not appreciably alter the ability of yeast to survive an
-factor-induced growth arrest (16).
Perhaps it should come as no surprise that while the in vitro activation of CMKA and CMKB may correlate with the ability of the heterologous proteins to support growth, the in vivo target(s) involved in causing the phenotypes may be considerably more complex. For example, two essential CaM binding proteins in addition to CMKA and CMKB have been identified in A. nidulans. The Ca2+/CaM-dependent phosphatase, calcineurin, and MyoA, a class I myosin, are each required for fungal growth (39, 24). Additionally, a recently identified homologue of S. cerevisiae Spc110p and S. pombe Pcp1p would be predicted to perform an essential mitotic role in A. nidulans based on the null phenotype in yeast (10a). Therefore, alterations in CaM binding or activation of at least five CaM binding proteins may be contributing to the inability of the heterologous proteins to functionally replace the endogenous A. nidulans CaM. It will be an interesting challenge to dissect the multiple, essential functions of Ca2+/CaM-dependent and -independent pathways in the growth of this fungus.
National Institutes of Health grant GM-33976 awarded to A.R.M. funded this study.
|
|
|---|
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»